Eli Lilly and Company

Deputy European Union (EU) Qualified Person for Pharmacovigilance (m/f/d)

Paris, Île-de-France, France

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Deputy European Union (EU) Qualified Person for Pharmacovigilance (m/f/d)

Employment Type: Full-time

Position Overview

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Responsibilities

  • Deputise for the EU Qualified Person for Pharmacovigilance: Fulfill the legal and regulatory requirements for the EU Qualified Person for Pharmacovigilance (QPPV) role, as defined by current EU legislation and guidelines, in the absence of or as delegated by the EU QPPV.
  • Ensure appropriate coordination and coverage with the QPPV, including timely provision of all necessary information to support the role.
  • Maintain up-to-date awareness of EU regulatory developments; provide timely feedback to GPS leadership and guidance to the Medicines Quality Organisation as needed.
  • Review and contribute expert input to EU regulatory submissions, PASS protocols, and actions related to emerging safety concerns, ensuring effective risk minimisation and compliance with timeliness, accuracy, and completeness of safety data submitted to Competent Authorities and EMA.
  • Provide QPPV input to GPLC in the absence of or as delegated by the QPPV, and fulfill all other delegated QPPV responsibilities per Good Pharmacovigilance Practice (GVP) guidelines.
  • Actively contribute to the GPS Leadership Team, SRC, GPLC, and other committees as appropriate; offer strategic and technical advice across global regulatory and medical functions.
  • Serve as an independent expert on safety issues, maintaining strong links with Global Regulatory Affairs, and offering consultancy on safety-related content in EU submissions, CHMP responses, and product information documents.
  • Provide external technical leadership through engagement in pharmacovigilance forums and integrate shared learning into the organization.
  • Deliver training, coaching, and mentorship to safety surveillance scientists, Global Patient Safety physicians, clinical researchers, and other relevant medical and regulatory personnel.
  • Support recruitment and succession planning by advising on candidates for managerial and physician roles, as requested.

What challenges await you?

  • Deputise for the EU QPPV as required, fulfilling all legal and regulatory obligations in their absence and as delegated.
  • Provide strategic and technical pharmacovigilance advice to Global Patient Safety (GPS) and other regulatory and medical functions within the Medicines Development Unit.
  • Actively contribute to the GPS Leadership Team, Safety Review Committee (SRC), and other relevant committees.
  • Demonstrate GPS expertise and leadership through training, coaching, and mentoring.
  • Represent the EU QPPV on the Global Product Labelling Committee (GPLC) as needed.

Your Profile

If you can look back on the following successes in your career to date, you bring the best prerequisites with you:

  • Medical degree with clinical experience, ideally with a global perspective and eligibility to work/reside in the EU/EEA.
  • Minimum 5 years in pharmacovigilance, with solid understanding of epidemiology, drug safety regulations, and benefit-risk assessment methodologies.
  • Proven clinical judgment, problem-solving, and decision-making skills, especially under pressure.
  • Excellent communication, coaching, and influencing abilities across diverse stakeholders and seniority levels.
  • Strong writing, presentation, and interpersonal skills; effective in team-based and independent work environments.
  • Data-driven mindset with familiarity in quality systems and a commitment to continuous learning and shared knowledge.

Company Information

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Skills

Pharmacovigilance
Regulatory Affairs
EU Legislation
Medicines Development
Product Labelling
Safety Review
Risk Management
Regulatory Submissions
PASS Protocols

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI